A Second Perspective: Discussing a4b7 integrin blocking in moderate to severe ulcerative colitis: Looking at 1st gen PTG-100 and MORF-057

Executed on:Feb 4, 2022 11:00 AM EDT

Call Duration:30 minutes

Expert Profile

ExpertBlinded Expert

Institution: NYUAssistant Professor of Medicine in the Division of Gastroenterology at NYU Grossman School of Medicine & gastroenterologist at the IBD Center at NYU Langone Health.
Manages 350 unique patients with Crohn's disease annually. 
Extremely familiar with study data and was PI on trials from Vedanta and Gilead in UC.

Interview Goal

Discuss a4b7 and potential of 2nd gen PN-943 and MORF-057 in treating moderate to severe ulcerative colitis

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.